跳至主要内容
临床试验/NCT06715189
NCT06715189尚未招募不适用

Correlation Between Serum Adiponectin and Resistin Levels and Degree of Hepatic Fibrosis In Metabolic Dysfunction _Associated Steatotic Liver Disease (MASLD)With Type2 Diabetes Mellitus

Sohag University0 个研究点目标入组 80 人开始时间: 2024年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
主要终点
degree of hepatic fibrosis in MASLD with type 2 diabetes mellitus

研究概览

简要总结

Metabolic dysfunction asociated steatotic liver disease prevalence is 25%world wide diabetic patients have a risk for MASLD then have hepatic fibrosis so we study correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic fibrosis In Metabolic dysfunction asociated steatotic liver disease in patients with type2 Diabetes Mellitus

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients of both sex who have type2 Diabetes Mellitus for less than five years

排除标准

  • alcholics ,chronic liver disease elevated liver functions , sever infection

结局指标

主要结局

degree of hepatic fibrosis in MASLD with type 2 diabetes mellitus

时间窗: 1 year

adiponectineand resistine level with degree of hepatic fibrosis in MASLD pt. with type 2 DM

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elzahraa Kadry Mohamed

Teaching assistant fellow At sohag teaching hospital

Sohag University

相似试验